[HTML][HTML] Current trends in pharmaceutical treatment of dry eye disease: A review

HB Mohamed, BN Abd El-Hamid, D Fathalla… - European Journal of …, 2022 - Elsevier
Dry eye disease (DED), keratoconjunctivitis sicca or dysfunctional tear syndrome, is the most
prevalent ophthalmic disease which affects a substantial segment of people worldwide with …

Advances in dry eye disease treatment

EC O'Neil, M Henderson… - Current opinion in …, 2019 - journals.lww.com
Clinicians have more options at their disposal in the treatment of dry eye disease than ever
before, including topical medications and devices. SYNOPSIS In this article, we review …

Management of meibomian gland dysfunction: a review

S Sabeti, A Kheirkhah, J Yin, R Dana - Survey of ophthalmology, 2020 - Elsevier
Meibomian gland dysfunction is the leading cause of evaporative dry eye disease and is
one of the most common conditions encountered by eye care providers. The disorder is …

Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee

D Thiboutot, R Anderson, F Cook-Bolden… - Journal of the American …, 2020 - Elsevier
In 2017, a National Rosacea Society Expert Committee developed and published an
updated classification of rosacea to reflect current insights into rosacea pathogenesis …

Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape

JD Sheppard, KK Nichols - Ophthalmology and Therapy, 2023 - Springer
Meibomian gland dysfunction (MGD) is highly prevalent and is the leading cause of
evaporative dry eye disease (DED). MGD is characterized by a reduction in meibum …

BCLA CLEAR-Anatomy and physiology of the anterior eye

LE Downie, S Bandlitz, JPG Bergmanson… - Contact Lens and …, 2021 - Elsevier
A key element of contact lens practice involves clinical evaluation of anterior eye health,
including the cornea and limbus, conjunctiva and sclera, eyelids and eyelashes, lacrimal …

Antibiotic treatment for dry eye disease related to meibomian gland dysfunction and blepharitis–A review

RR Vernhardsdottir, MS Magno, L Hynnekleiv… - The ocular …, 2022 - Elsevier
Background Dry eye disease (DED) is among the most prevalent ophthalmic conditions but
is often underdiagnosed and mistreated. Antibiotics are regularly used to treat DED caused …

Efficacy and safety of a vectored thermal pulsation system (Lipiflow®) in the treatment of meibomian gland dysfunction: a systematic review and meta-analysis

J Hu, S Zhu, X Liu - Graefe's Archive for Clinical and Experimental …, 2022 - Springer
Purpose To investigate the efficacy and safety of a vectored thermal pulsation system
(Lipiflow®) in the treatment of dry eye disease resulting from meibomian gland dysfunction …

Latest evidences on meibomian gland dysfunction diagnosis and management

E Villani, L Marelli, A Dellavalle, M Serafino, P Nucci - The ocular surface, 2020 - Elsevier
Meibomian gland dysfunction (MGD) can be considered the leading cause of dry eye
disease (DED) and one of the most common ophthalmic disorders found in clinical practice …

[HTML][HTML] Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized …

SL Watson, LW Jones, F Stapleton, M Hinds, A Ng… - The Ocular Surface, 2023 - Elsevier
Purpose Meibomian gland dysfunction (MGD) is a chronic progressive disease with
downstream effects on ocular signs and symptoms. AZR-MD-001 is a selenium sulfide …